You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models

Article Text

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models

https://doi.org/10.1136/jitc-2020-SITC2020.0605

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.